These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]
Edwards launches US pivotal Centera self-expanding TAVR study
Edwards Lifesciences (NYSE:EW) said yesterday it launched a U.S.-based pivotal trial of its self-expanding Centera transcatheter aortic valve, exploring its use in treating severe symptomatic aortic stenosis in intermediate risk patients. The Centera valve is designed to be repositionable and retrievable, and is delivered through the use of a 14 French motorized delivery system in which […]
Report: Edwards to open 600-job facility in Ireland
Edwards Lifesciences (NYSE:EW) is looking to open a new facility in Limerick, Ireland, that could bring in up to 600 new jobs for the region, according to a report from the Limerick Leader. The Irvine, Calif.-based company is looking to build a new 170,000 square foot facility in the area, and hopes to complete the project […]
M&A chatter: Could J&J be eyeing Boston Scientific, Edwards? Did Medtronic pay too much for Mazor?
The M&A rumors in medtech are in full swing, with a Wells Fargo analyst suggesting that Johnson & Johnson (NYSE:JNJ) could be eyeing major cardiac device players Boston Scientific (NYSE:BSX) and Edwards Lifesciences (NYSE:EW) for a big-ticket buy, while a Motley Fool analyst thinks Medtronic (NYSE:MDT) may have paid too much to pick up Mazor Robotics (NSDQ:MZOR). Wells Fargo analyst […]
Edwards shares fall despite Q2 EPS, sales beat
Shares in Edwards Lifesciences (NYSE:EW) have fallen in early morning trading today despite the medical device maker posting second quarter earnings that topped expectations on Wall Street. The Irvine, Calif.-based company posted profits of $282.7 million, or $1.32 per share, on sales of $943.7 million for the three months ended June 30, for bottom-line growth of […]
CMS opens NCA to reconsider TAVR coverage
The Centers for Medicare and Medicaid have opened a National Coverage Analysis looking to reconsider its National Coverage Determination for transcatheter aortic valve replacement procedures. Medicare’s NCD for TAVR was established in 2012 with strict criteria for reimbursement and procedure performance that limited TAVR to high-volume hospitals and medical centers. Requirements in the 2012 decision […]
Edwards Lifesciences prices $600m senior notes offering
Edwards Lifesciences (NYSE:EW) this week priced a $600 million offering of senior notes due 2028. The Irvine, Calif.-based company inked an underwriting agreement to issue and sell 4.3% senior unsecured notes due 2028 through several underwriters, according to an SEC filing. Underwriters included in the offering are Merrill Lynch, Pierce, Fenner & Smith and J.P. Morgan […]
EuroPCR 2018 Roundup: Edwards reportedly pauses Centera valve EU launch
Edwards Lifesciences’ (NYSE:EW) European launch of its Centera valve has been temporarily paused as the company looks to modify the device’s delivery system, according to a Leerink Partner letter to investors highlighting presentations from the EuroPCR 2018 Annual Meeting. Delivery of the unit and its use in clinical cases are slated to resume during the third […]
MassDevice EuroPCR 2018 Roundup
Valve Tech Roundup – Transcath heart valves getting safer, seeing expanded use Abbott touts initial data from Portico TAVR study Abbott (NYSE:ABT) today released 30-day data from a study of its Portico transcatheter aortic valve replacement, touting excellent clinical outcomes and low rates of death, disabling stroke and paravalvular leak. The real-world, multicenter, prospective, single-arm […]
8 companies commercializing transcatheter mitral valve replacements
Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used […]
Edwards inks $400m share repurchase deal
Edwards Lifesciences (NYSE:EW) said today it inked a deal to repurchase an aggregate of $400 million in its common shares. Under terms of the new share repurchasing deal, Edwards said it will receive approximately 2.5 million shares this month, with the final number of shares to be repurchased based on the volume weighted average share price […]
- 1
- 2
- 3
- …
- 39
- Next Page »
MassDevice Network
@MassDevice
LinkedIn